Author Correction: Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction Notice: Inhibition of TRIP-Br2, a key modulator of lipid breakdown, thermogenic activity, and oxidative processes, mitigates obesity and insulin resistance linked to diet.

  • By

  • Chong Wee Liew

  • Jeremie Boucher

  • Jit Kong Cheong

  • Cecile Vernochet

  • Ho-Jin Koh

  • Cristina Mallol

  • Kristy Townsend

  • Dominique Langin

  • Dan Kawamori

  • Jiang Hu

  • Yu-Hua Tseng

  • Marc K Hellerstein

  • Stephen R Farmer

  • Laurie Goodyear

  • Alessandro Doria

  • Matthias Blüher

  • Stephen I-Hong Hsu

  • Rohit N Kulkarni

  • September 9, 2026

Share

Objective:

To correct errors in the Supplementary Information of a previously published study.

Approach:
  • Correction of Figures: The protein plot in Supplementary Fig. 3a was corrected from 'Epi/HF' to 'SQ/HF'.
  • Correction of Images: Supplementary Fig. 12c was amended to include correct representative oil-red-O-stained images of differentiated 3T3-L1 adipocyte cells.
Key Findings:
  • The label in Supplementary Fig. 3a was corrected from 'Epi/HF' to 'SQ/HF'.
  • Supplementary Fig. 12c was amended to include correct representative oil-red-O-stained images of differentiated 3T3-L1 adipocyte cells.
Conclusion:

The notice addresses specific inaccuracies in the supplementary materials of the original publication.

Sources:

Original Source(s)

Related Content